Company profilePharmaceutical#785 of 1,318 in Pakistan✓ No DRAP alerts

MICKO PHARMA

Pharmaceutical company · 10 brands · 5 molecules

Ranked #52 of 100 companies in Gastro

10 registered products 7 pharmaceutical brands 5 distinct molecules 0 DRAP alerts

Company overview

10
registered products
7
pharmaceutical brands
5
distinct molecules
3
therapeutic classes
0
DRAP alerts

MICKO PHARMA is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 10 product registrations across 5 distinct molecules. Its portfolio is concentrated in Gastro and Ear Conditions. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by MICKO

5 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Therapeutic classes

Gastro · 2Ear Conditions · 1Allergy · 1

Conditions treated

Colic/Constipation · 2Soften Ear Wax · 1Oral Allergy/Infections · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO1 products · Rs 47.5 – Rs 47.5
Servaid4 products · Rs 28.9 – Rs 48
Median across source: Rs 47.5

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

EFROZE CHEMICAL INDUSTRIES (PVT) LTD. holds 47 molecules not in this portfolio
Aluminium HydroxideAluminium Hydroxide And OxideAspirinBisoprololCastor OilCelecoxib
PHARMAKO PAKISTAN holds 2 molecules not in this portfolio
Ascorbic AcidGlucosamine
Albro Pharmaceuticals holds 21 molecules not in this portfolio
AdapaleneAdapleneBetamethasoneClindamycinClioquinolDesloratadine

Get the full profile for MICKO

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.